ProShares - UltraShort Nasdaq Biotechnology (BIS)

NASDAQ Financial Services Asset Management - Leveraged

ProShares - UltraShort Nasdaq Biotechnology operates in the Asset Management - Leveraged industry of the Financial Services sector, headquartered in Bethesda, MD, US. The stock last traded at $11.26, down 0.04% on the session, giving a market capitalisation of $1.8M. Its beta of -1.19 implies it has historically moved less than the broad market.

The ProShares UltraShort Nasdaq Biotechnology fund is engineered to achieve daily returns that are precisely two times the inverse (-2x) of the Nasdaq Biotechnology Index's daily performance. This objective is measured before accounting for any associated fees and operational expenses.

ProShares - UltraShort Nasdaq Biotechnology is most often compared with the following Financial Services names: